Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 553530106 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 9.1% |
4/24/2025
Event 3/31/2025
|
||
|
Harlan B. Korenvaes
13G
|
5.9% |
8/11/2026
Event 8/4/2026
|
||
| Harlan B. Korenvaes | 5.9% | |||
| Spruce Trust | 5.7% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
American Century Investment Management, Inc.
13G/A
|
4.7% |
5/1/2026
Event 3/31/2026
|
||
| American Century Investment Management, Inc. | 4.7% | |||
| American Century Companies, Inc. | 4.7% | |||
| Stowers Institute for Medical Research | 4.7% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 66 | 896 k | $111 M |
| 2026 Q2 | 499 | 52.7 M | $5.53 B |
| 2026 Q1 | 429 | 47.0 M | $4.33 B |
| 2025 Q4 | 440 | 49.6 M | $4.16 B |
| 2025 Q3 | 440 | 46.7 M | $4.30 B |
| 2025 Q2 | 412 | 48.2 M | $4.10 B |
| 2025 Q1 | 403 | 47.1 M | $3.66 B |
| 2024 Q4 | 403 | 45.9 M | $3.43 B |
| 2024 Q3 | 428 | 45.6 M | $3.93 B |
| 2024 Q2 | 435 | 44.8 M | $3.55 B |
| 2024 Q1 | 482 | 45.5 M | $4.41 B |
| 2023 Q4 | 481 | 44.3 M | $4.48 B |
| 2023 Q3 | 431 | 44.6 M | $4.36 B |
| 2023 Q2 | 443 | 43.9 M | $4.17 B |
| 2023 Q1 | 394 | 42.5 M | $3.57 B |
| 2022 Q4 | 393 | 43.4 M | $3.55 B |
| 2022 Q3 | 372 | 42.8 M | $3.12 B |
| 2022 Q2 | 367 | 42.2 M | $3.17 B |
| 2022 Q1 | 382 | 44.0 M | $3.75 B |
| 2021 Q4 | 397 | 42.2 M | $3.54 B |
| 2021 Q3 | 368 | 42.2 M | $3.38 B |
| 2021 Q2 | 361 | 42.2 M | $3.79 B |
| 2021 Q1 | 388 | 43.4 M | $3.91 B |
| 2020 Q4 | 378 | 42.5 M | $3.58 B |
| 2020 Q3 | 347 | 41.0 M | $2.60 B |
| 2020 Q2 | 365 | 40.0 M | $2.91 B |
| 2020 Q1 | 330 | 41.1 M | $2.26 B |
| 2019 Q4 | 380 | 43.5 M | $3.41 B |
| 2019 Q3 | 333 | 43.3 M | $3.14 B |
| 2019 Q2 | 349 | 43.2 M | $3.22 B |
| 2019 Q1 | 347 | 42.7 M | $3.52 B |
| 2018 Q4 | 338 | 42.6 M | $3.27 B |
| 2018 Q3 | 341 | 44.5 M | $3.92 B |
| 2018 Q2 | 340 | 44.2 M | $3.74 B |
| 2018 Q1 | 334 | 44.5 M | $4.08 B |
| 2017 Q4 | 317 | 42.6 M | $4.11 B |
| 2017 Q3 | 298 | 43.1 M | $3.26 B |
| 2017 Q2 | 304 | 43.7 M | $3.76 B |
| 2017 Q1 | 313 | 44.9 M | $4.61 B |
| 2016 Q4 | 313 | 44.5 M | $4.12 B |
| 2016 Q3 | 291 | 47.6 M | $3.49 B |
| 2016 Q2 | 309 | 48.7 M | $3.44 B |
| 2016 Q1 | 284 | 48.2 M | $3.67 B |
| 2015 Q4 | 270 | 52.4 M | $2.95 B |
| 2015 Q3 | 255 | 55.9 M | $3.41 B |
| 2015 Q2 | 239 | 53.7 M | $3.75 B |
| 2015 Q1 | 240 | 52.5 M | $3.80 B |
| 2014 Q4 | 239 | 52.5 M | $4.28 B |
| 2014 Q3 | 233 | 52.3 M | $4.47 B |
| 2014 Q2 | 237 | 56.6 M | $5.42 B |
| 2014 Q1 | 230 | 52.1 M | $4.52 B |